2-Anilino-4-aryl-1,3-thiazole inhibitors of valosin-containing protein (VCP or p97).
about
Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell deathThe p97/VCP ATPase is critical in muscle atrophy and the accelerated degradation of muscle proteinsTargeting β-tubulin:CCT-β complexes incurs Hsp90- and VCP-related protein degradation and induces ER stress-associated apoptosis by triggering capacitative Ca2+ entry, mitochondrial perturbation and caspase overactivation.p97-containing complexes in proliferation control and cancer: emerging culprits or guilt by association?The complexities of p97 function in health and diseaseProteotoxic crisis, the ubiquitin-proteasome system, and cancer therapy.Proteostasis regulation at the endoplasmic reticulum: a new perturbation site for targeted cancer therapy.Pharmacological targeting of valosin containing protein (VCP) induces DNA damage and selectively kills canine lymphoma cellsInhibitors of the AAA+ chaperone p97Structure-Activity Study of Bioisosteric Trifluoromethyl and Pentafluorosulfanyl Indole Inhibitors of the AAA ATPase p97.Allosteric Indole Amide Inhibitors of p97: Identification of a Novel Probe of the Ubiquitin Pathway.Synthesis and biological evaluation of N-aryl-4-aryl-1,3-thiazole-2-amine derivatives as direct 5-lipoxygenase inhibitors.Perturbations to the ubiquitin conjugate proteome in yeast δubx mutants identify Ubx2 as a regulator of membrane lipid composition.VCP inhibitors induce endoplasmic reticulum stress, cause cell cycle arrest, trigger caspase-mediated cell death and synergistically kill ovarian cancer cells in combination with Salubrinal.The drug diazaborine blocks ribosome biogenesis by inhibiting the AAA-ATPase Drg1.Synthesis of Substituted 2-Amino-1,3-oxazoles via Copper-Catalyzed Oxidative Cyclization of Enamines and N,N-Dialkyl Formamides.Drosophilaand Mouse Models of Hereditary Myopathy Caused by Mutations in VCP/p97
P2860
Q28295447-7F1CDEAF-E3CB-4C12-812B-5D8A7DE90741Q28513793-760D363B-FFA8-4044-93A5-500FB8ED1FBBQ30532061-60890D77-1990-4691-AC20-B25C22C2F121Q34318246-6A4199EC-8239-493B-A7FC-B20E3587C269Q34632255-D4D0198B-2AA4-45C6-AEF7-EA7EF8931CFDQ35408665-A822FA03-02C6-4D9E-9AAB-7681F2E2A019Q35469778-9A3B13D0-CA94-4BA5-831A-2ADDC8D891F6Q35672293-C1AC1BC3-7A4B-4DDF-9886-BA2245DBF7F8Q36078289-D0C2D849-4BB3-4C5E-997E-8F5297EC424BQ36367307-4FAC789C-4259-431E-AA07-319188423F46Q36579840-DA382001-ACB6-4D18-8948-3BDA2E112706Q39382602-82781EFF-915B-436D-969F-E6F8321B3332Q39398325-D3B9AE95-6A1D-4C5C-A504-D78E45565C41Q41895056-E29F25F6-785A-4349-BDD1-079262A57850Q41954752-41EF8FDE-D717-4A0C-B94C-5A336691D5B9Q48172419-FE64394C-1BB4-4070-A8A0-0DD497366708Q58623082-E20594FB-D100-45C3-8D60-B8392C3B284F
P2860
2-Anilino-4-aryl-1,3-thiazole inhibitors of valosin-containing protein (VCP or p97).
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
2-Anilino-4-aryl-1,3-thiazole inhibitors of valosin-containing protein (VCP or p97).
@en
2-Anilino-4-aryl-1,3-thiazole inhibitors of valosin-containing protein (VCP or p97).
@nl
type
label
2-Anilino-4-aryl-1,3-thiazole inhibitors of valosin-containing protein (VCP or p97).
@en
2-Anilino-4-aryl-1,3-thiazole inhibitors of valosin-containing protein (VCP or p97).
@nl
prefLabel
2-Anilino-4-aryl-1,3-thiazole inhibitors of valosin-containing protein (VCP or p97).
@en
2-Anilino-4-aryl-1,3-thiazole inhibitors of valosin-containing protein (VCP or p97).
@nl
P2093
P1476
2-Anilino-4-aryl-1,3-thiazole inhibitors of valosin-containing protein (VCP or p97).
@en
P2093
Ashley Peterson
Burt Richards
Daniel M Cimbora
Daniel P Parker
J Adam Willardsen
Ju-Fen Zhu
Kirill Ostanin
Rosann Robinson
Thaylon Davis
Zhong-Hua Gao
P304
P356
10.1016/J.BMCL.2010.01.058
P407
P577
2010-01-21T00:00:00Z